Acta Med. 2002, 45: 19-27

https://doi.org/10.14712/18059694.2019.52

The Influence of Oxime Selection on the Efficacy of Antidotal Treatment of Soman-Poisoned Rats

Jiří Kassa, Josef Fusek

Purkyně Military Medical Academy, Department of Toxicology, Hradec Králové, Czech Republic

Received November 1, 2001
Accepted April 1, 2002

References

1. Bajgar J, Patočka J, Herink J, Fusek J, Hrdina J. Effect of benactyzine, atropine and chlorpromazine on blood-brain barrier permeability in rats. Activ Nerv Sup 1978; 20:56–62.
2. Bajgar J. Present view on toxidynamics of soman poisoning. Acta Med (Hradec Králové) 1996; 39:101–5.
3. Chang EC, Foster RE, Beers ET, Rickett DL, Filbert MG. Neurophysiological concomitants of soman-induced respiratory depression in awake, behaving guinea pigs. Toxicol Appl Pharmacol 1990; 102:233–8. <https://doi.org/10.1016/0041-008X(90)90023-N>
4. Clement JG. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat. Biochem Pharmacol 1982; 31:1283–7. <https://doi.org/10.1016/0006-2952(82)90017-X>
5. Clement JG. Central activity of acetylcholinesterase oxime reactivators. Toxicol Appl Pharmacol 1992; 112:104–9. <https://doi.org/10.1016/0041-008X(92)90285-Z>
6. Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317–31. <https://doi.org/10.1002/jat.2550140502>
7. Ellenwood EHJr, Nikaido AM, Gupta SK, Heatherly DG, Nishita JK. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics. J Pharmacol Exp Ther 1990; 255:1133–41.
8. Fleisher JH, Harris JW. Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochem Pharmacol 1965; 14:641–9. <https://doi.org/10.1016/0006-2952(65)90082-1>
9. Kadar T, Raveh L, Cohen G et al. Distribution of 3H–soman in mice. Arch Toxicol 1985; 58:45–9. <https://doi.org/10.1007/BF00292616>
10. Kassa J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101:167–74. <https://doi.org/10.1016/0300-483X(95)03091-S>
11. Kassa J, Bajgar J. Changes of acetylcholinesterase activity in various parts of brain following non-treated and treated soman poisoning in rats. Mol Chem Neuropathol 1998; 33:175–84. <https://doi.org/10.1007/BF02815180>
12. Kassa J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 1999; 132:111–8. <https://doi.org/10.1016/S0300-483X(98)00146-2>
13. Kassa, J, Fusek J. The influence of anticholinergic drug selection on the efficacy of antidotal treatment of soman-poisoned rats. Toxicology 2000; 154:67–73. <https://doi.org/10.1016/S0300-483X(00)00322-X>
14. Kok A. REM sleep pathway and anticholinesterase intoxication: a mechanism for nerve agent-induced central respiration failure. Med Hypotheses 1993; 41:141–9. <https://doi.org/10.1016/0306-9877(93)90061-T>
15. Lallement G, Dorandeu F, Filliat P, Carpentier P, Baille V, Blanchet G. Medical management of organophosphate-induced seizures. J Physiol (Paris) 1998; 92:369–73. <https://doi.org/10.1016/S0928-4257(99)80007-2>
16. Lundy PM, Shih T-M. Examination of the role of central cholinergic mechanisms in the therapeutic effects of HI-6 in organophosphate poisoning. J Neurochem 1983; 40:1321–7. <https://doi.org/10.1111/j.1471-4159.1983.tb13573.x>
17. Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51–66. <https://doi.org/10.1016/0163-7258(93)90066-M>
18. McDonough JR, Shih T-M. Neuropharmacological mechanisms of nerve agent – induced seizure and neuropathology. Neurosci Biobehav Rev 1997; 21:559–79. <https://doi.org/10.1016/S0149-7634(96)00050-4>
19. Ohtomi S, Takase M, Kunagoi F. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Arm Force Med Ser 1996; 69:97–102.
20. Rousseaux CG, Dua AK. Pharmacology of HI-6, an H series oximes. Can J Physiol Pharmacol 1989; 67:1183–9. <https://doi.org/10.1139/y89-188>
21. Saadeh AM, Farsakh NA, Al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart 1997; 77:461–8. <https://doi.org/10.1136/hrt.77.5.461> <PubMed>
22. Sachs, L.: Angewandte Statistik, 2nd ed. Springer, Berlin, 1992:p. 207.
23. Shih T-M, Whalley ChE, Valdes JJ. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol Lett 1991; 55:131–47.
24. Shih T-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 1993; 67:637–46. <https://doi.org/10.1007/BF01974071>
25. Taylor P. Anticholinesterase agents. In: The Pharmacological Basis of Therapeutics, 9th ed. Eds.: Hardman JG, Limbird LE. McGraw Hill, New York, USA, 1996: pp. 161–76.
26. Tryphonas L, Clement JG. Histomorphogenesis of soman-induced encephalocardiomyopathy in Sprangue-Dawley rats. Toxicol Pathol 1995; 23:393–7. <https://doi.org/10.1177/019262339502300316>
27. van Helden HPM, Busker RW, Melchers BPC, Brijunzeel PLB. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996; 70:779–86. <https://doi.org/10.1007/s002040050340>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive